Comprehensive identification of RNA-protein interactions in any organism using orthogonal organic phase separation (OOPS).


Journal

Nature biotechnology
ISSN: 1546-1696
Titre abrégé: Nat Biotechnol
Pays: United States
ID NLM: 9604648

Informations de publication

Date de publication:
02 2019
Historique:
received: 16 05 2018
accepted: 19 11 2018
pubmed: 5 1 2019
medline: 13 4 2019
entrez: 5 1 2019
Statut: ppublish

Résumé

Existing high-throughput methods to identify RNA-binding proteins (RBPs) are based on capture of polyadenylated RNAs and cannot recover proteins that interact with nonadenylated RNAs, including long noncoding RNA, pre-mRNAs and bacterial RNAs. We present orthogonal organic phase separation (OOPS), which does not require molecular tagging or capture of polyadenylated RNA, and apply it to recover cross-linked protein-RNA and free protein, or protein-bound RNA and free RNA, in an unbiased way. We validated OOPS in HEK293, U2OS and MCF10A human cell lines, and show that 96% of proteins recovered were bound to RNA. We show that all long RNAs can be cross-linked to proteins, and recovered 1,838 RBPs, including 926 putative novel RBPs. OOPS is approximately 100-fold more efficient than existing methods and can enable analyses of dynamic RNA-protein interactions. We also characterize dynamic changes in RNA-protein interactions in mammalian cells following nocodazole arrest, and present a bacterial RNA-interactome for Escherichia coli. OOPS is compatible with downstream proteomics and RNA sequencing, and can be applied in any organism.

Identifiants

pubmed: 30607034
doi: 10.1038/s41587-018-0001-2
pii: 10.1038/s41587-018-0001-2
pmc: PMC6591131
mid: EMS83427
doi:

Substances chimiques

Cross-Linking Reagents 0
Glycoproteins 0
Proteome 0
RNA, Bacterial 0
RNA, Long Noncoding 0
RNA, Messenger 0
RNA-Binding Proteins 0
RNA 63231-63-0
Nocodazole SH1WY3R615
Thymidine VC2W18DGKR

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

169-178

Subventions

Organisme : Wellcome Trust
ID : 110071
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UP_A600_1023
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U105185859
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00025/7
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 110170
Pays : United Kingdom

Commentaires et corrections

Type : ErratumIn

Références

Proc Natl Acad Sci U S A. 2016 Oct 11;113(41):11591-11596
pubmed: 27671629
Cell. 2018 May 31;173(6):1495-1507.e18
pubmed: 29706546
Science. 2017 May 26;356(6340):
pubmed: 28495876
Nat Protoc. 2014 May;9(5):989-1009
pubmed: 24705597
Methods. 2014 Feb;65(3):274-87
pubmed: 24184352
Genome Announc. 2016 Nov 10;4(6):
pubmed: 27834703
J Cell Biol. 2017 Nov 6;216(11):3639-3653
pubmed: 28928132
J Biol Chem. 2014 Jul 18;289(29):20359-69
pubmed: 24898252
Nucleic Acids Res. 2016 Jan 4;44(D1):D447-56
pubmed: 26527722
Mol Microbiol. 2017 Jul;105(2):177-187
pubmed: 28419603
Proc Natl Acad Sci U S A. 2008 Oct 14;105(41):15779-84
pubmed: 18840688
Mol Cell. 2016 Aug 18;63(4):696-710
pubmed: 27453046
Nat Commun. 2016 Jul 05;7:12128
pubmed: 27378189
Curr Biol. 2013 Jul 8;23(13):R553-6
pubmed: 23845239
Mol Cell. 2009 Dec 25;36(6):932-41
pubmed: 20064460
RNA Biol. 2014;11(8):1051-60
pubmed: 25482897
J Biol Chem. 2011 Feb 18;286(7):5328-37
pubmed: 21123178
Biol Direct. 2013 Jun 07;8:12
pubmed: 23758897
Proc Natl Acad Sci U S A. 2015 Mar 24;112(12):E1433-42
pubmed: 25713383
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):15822-7
pubmed: 21903929
Nat Methods. 2016 Jun;13(6):508-14
pubmed: 27018577
Proteomics. 2015 Sep;15(18):3163-8
pubmed: 25656970
Nucleic Acids Res. 2018 Mar 16;46(5):2699
pubmed: 29425356
Nature. 2015 May 14;521(7551):232-6
pubmed: 25915022
Elife. 2016 May 20;5:
pubmed: 27198188
Nucleic Acids Res. 2014 Jan;42(Database issue):D114-22
pubmed: 24185695
Sci Rep. 2012;2:517
pubmed: 22816040
J Biol Chem. 2011 Mar 25;286(12):10702-11
pubmed: 21266579
Sci Rep. 2017 Aug 4;7(1):7292
pubmed: 28779177
J Mol Biol. 2014 May 15;426(10):2070-81
pubmed: 24636949
Bioinformatics. 2012 Jan 15;28(2):288-9
pubmed: 22113085
Nucleic Acids Res. 2018 Jan 4;46(D1):D1091-D1106
pubmed: 29149325
Front Mol Biosci. 2017 Oct 23;4:71
pubmed: 29109951
Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10011-6
pubmed: 18626022
Nature. 2002 Dec 19-26;420(6917):821-4
pubmed: 12490950
Nat Commun. 2016 Jun 02;7:11814
pubmed: 27251117
Anal Chem. 2014 Jul 15;86(14):7150-8
pubmed: 24927332
Eur J Biochem. 1980 Nov;112(2):323-30
pubmed: 7460925
Nat Methods. 2018 Mar;15(3):213-220
pubmed: 29431736
Proc Natl Acad Sci U S A. 2018 Apr 24;115(17):E3879-E3887
pubmed: 29636419
Genes Dev. 2016 May 15;30(10):1224-39
pubmed: 27198227
Cytoskeleton (Hoboken). 2012 Aug;69(8):555-65
pubmed: 22736583
Biochim Biophys Acta. 1999 Jul 13;1432(2):222-33
pubmed: 10407144
Nat Commun. 2015 Dec 03;6:10127
pubmed: 26632259
Mol Cell. 2011 Feb 4;41(3):343-53
pubmed: 21292166
Nucleic Acids Res. 2017 Jan 4;45(D1):D353-D361
pubmed: 27899662
Cell. 2002 Nov 1;111(3):407-17
pubmed: 12419250
Science. 1993 Jan 15;259(5093):365-8
pubmed: 8420004
Nature. 2011 Apr 7;472(7341):120-4
pubmed: 21423168
Nat Rev Genet. 2013 Apr;14(4):275-87
pubmed: 23478349
Mol Cell. 2012 Jun 8;46(5):674-90
pubmed: 22681889
Wiley Interdiscip Rev RNA. 2018 May;9(3):e1465
pubmed: 29341429
Semin Cell Dev Biol. 2019 Feb;86:162-173
pubmed: 29574117
Nature. 2016 Nov 17;539(7629):452-455
pubmed: 27783602
J Cell Sci. 2001 Jan;114(Pt 2):281-91
pubmed: 11148130
J Biol Chem. 2015 Jan 16;290(3):1770-85
pubmed: 25451934
Mol Cell. 2015 Feb 5;57(3):433-44
pubmed: 25578875
J Proteome Res. 2017 Mar 3;16(3):1288-1299
pubmed: 28164708
Nat Rev Genet. 2011 Feb;12(2):99-110
pubmed: 21245828
Cell. 2013 Jun 6;153(6):1239-51
pubmed: 23746840
Bioinformatics. 2014 May 1;30(9):1290-1
pubmed: 24395753
Nucleic Acids Res. 2018 Jan 4;46(D1):D754-D761
pubmed: 29155950
Elife. 2015 Aug 25;4:
pubmed: 26305499
Mol Cell Proteomics. 2002 May;1(5):376-86
pubmed: 12118079
Nat Commun. 2017 Oct 26;8(1):1145
pubmed: 29074968
J Vis Exp. 2010 Jul 02;(41):
pubmed: 20644507
Biochem Biophys Res Commun. 2004 Feb 6;314(2):622-30
pubmed: 14733953
J Mass Spectrom. 1999 Feb;34(2):105-16
pubmed: 10093212
Cell Mol Life Sci. 2008 Oct;65(20):3168-81
pubmed: 18581050
Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7865-70
pubmed: 12766229
Nature. 2013 Nov 21;503(7476):371-6
pubmed: 24107992
Cell Res. 2015 Oct;25(10):1108-20
pubmed: 26206315
Nat Methods. 2015 Apr;12(4):357-60
pubmed: 25751142
Mol Cell Proteomics. 2012 Mar;11(3):M111.014050
pubmed: 22278370
Nucleic Acids Res. 2017 Jan 25;45(2):926-937
pubmed: 27625389
Trends Genet. 2012 Jul;28(7):314-22
pubmed: 22521614
J Proteome Res. 2014 Aug 1;13(8):3679-84
pubmed: 24909410
Cell. 2012 Jun 8;149(6):1393-406
pubmed: 22658674
RNA Biol. 2014;11(8):1040-50
pubmed: 25483039
Wiley Interdiscip Rev RNA. 2016 Jan-Feb;7(1):53-70
pubmed: 26564736
Nat Methods. 2017 Apr;14(4):417-419
pubmed: 28263959
Nat Protoc. 2006;1(2):581-5
pubmed: 17406285
Nucleus. 2010 Nov-Dec;1(6):447-59
pubmed: 21327086
Trends Endocrinol Metab. 2015 Dec;26(12):746-757
pubmed: 26520658
Cell Rep. 2016 Aug 2;16(5):1456-1469
pubmed: 27452465
Anal Biochem. 1987 Apr;162(1):156-9
pubmed: 2440339

Auteurs

Rayner M L Queiroz (RML)

Cambridge Centre for Proteomics, Department of Biochemistry, University of Cambridge, Cambridge, UK.

Tom Smith (T)

Cambridge Centre for Proteomics, Department of Biochemistry, University of Cambridge, Cambridge, UK.

Eneko Villanueva (E)

Cambridge Centre for Proteomics, Department of Biochemistry, University of Cambridge, Cambridge, UK. ev318@cam.ac.uk.

Maria Marti-Solano (M)

MRC Laboratory of Molecular Biology, Cambridge, UK.

Mie Monti (M)

Cambridge Centre for Proteomics, Department of Biochemistry, University of Cambridge, Cambridge, UK.

Mariavittoria Pizzinga (M)

MRC Toxicology Unit, University of Cambridge, Leicester, UK.

Dan-Mircea Mirea (DM)

Cambridge Centre for Proteomics, Department of Biochemistry, University of Cambridge, Cambridge, UK.

Manasa Ramakrishna (M)

MRC Toxicology Unit, University of Cambridge, Leicester, UK.

Robert F Harvey (RF)

MRC Toxicology Unit, University of Cambridge, Leicester, UK.

Veronica Dezi (V)

MRC Toxicology Unit, University of Cambridge, Leicester, UK.

Gavin H Thomas (GH)

Department of Biology, University of York, York, UK.

Anne E Willis (AE)

MRC Toxicology Unit, University of Cambridge, Leicester, UK.

Kathryn S Lilley (KS)

Cambridge Centre for Proteomics, Department of Biochemistry, University of Cambridge, Cambridge, UK. k.s.lilley@bioc.cam.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH